Human mesenchymal stem cells suppress allogeneic T cell responses in vitro:: Implications for allogeneic transplantation.

被引：0
|
作者：
Klyushnenkova, E [1 ]
Mosca, JD [1 ]
McIntosh, KR [1 ]
机构：
[1] Osiris Therapeut Inc, Baltimore, MD USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2652
引用
收藏
页码：642A / 642A
页数：1
相关论文
共 50 条
  • [21] In vitro monitoring of defibrotide prophylaxis for endothehal complications following allogeneic stem cell transplantation.
    Eissner, Gunther
    Wiesner, Julia
    Hahn, Nancy
    Iacobelli, Massimo
    Haubitz, Marion
    Andreesen, Reinhard
    Holler, Ernst
    BLOOD, 2006, 108 (11) : 841A - 842A
  • [22] Allogeneic related HLA mismatch mesenchymal stem cells for the treatment of engraftment failure following autologous hematopoietic stem cell transplantation.
    Fouillard, Loic
    Chapel, Alain
    Bories, Domnique
    Bouchet, Sandrine
    Rouard, Helene
    Herve, Patrick
    Gourmelon, Patrick
    Thierry, Dominique
    Gorin, Norbert C.
    BLOOD, 2006, 108 (11) : 724A - 724A
  • [23] Comparison of hematopoietic recovery following allogeneic blood stem cell transplantation and allogeneic bone marrow transplantation.
    Bishop, MR
    Tarantolo, SR
    MartinAlgarra, S
    Cowles, K
    Bierman, PJ
    Vose, JM
    Reed, EC
    Gross, TG
    Armitage, JO
    Pavletic, ZS
    Nasrati, K
    Kessinger, A
    BLOOD, 1995, 86 (10) : 1553 - 1553
  • [24] Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation
    Reading, James L.
    Sabbah, Shereen
    Busch, Sarah
    Tree, Timothy I. M.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2013, 18 (01) : 59 - 64
  • [25] Human mesenchymal stem cell-mediated suppression of allogeneic T cell responses: A cytokine analysis.
    Klyushnenkova, EN
    Shustova, V
    Mosca, JD
    Buyaner, D
    Hendricks, JK
    Moseley, AB
    McIntosh, KR
    FASEB JOURNAL, 1999, 13 (04): : A615 - A615
  • [26] Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation
    Mo, Feiyan
    Watanabe, Norihiro
    Omdahl, Kayleigh I.
    Burkhardt, Phillip M.
    Ding, Xiaoyun
    Hayase, Eiko
    Panoskaltsis-Mortari, Angela
    Jenq, Robert R.
    Heslop, Helen E.
    Kean, Leslie S.
    Brenner, Malcolm K.
    Tkachev, Victor
    Mamonkin, Maksim
    BLOOD, 2023, 141 (10) : 1194 - 1208
  • [27] T cell therapy in allogeneic stem cell transplantation
    Falkenburg, J. H. Frederik
    Heslop, Helen E.
    Barrett, A. John
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) : 136 - 141
  • [28] Sirolimus and thrombotic microangiopathy after allogeneic stem cell transplantation.
    Henry, NL
    Li, SL
    Kim, HT
    Magee, C
    Alyea, E
    Ho, V
    Lee, SJ
    Soiffer, R
    Antin, JH
    Cutler, C
    BLOOD, 2004, 104 (11) : 508A - 508A
  • [29] Subdural hematomas as complication of allogeneic stem-cell transplantation.
    Lauritzsen, GF
    Brinch, L
    Evensen, SA
    BONE MARROW TRANSPLANTATION, 1999, 23 : S5 - S5
  • [30] Causes of death by necropsy after allogeneic stem cell transplantation.
    Quiñones, MDP
    Palomino, EA
    Yabar, A
    Carrasco-Yalan, AA
    Castillo, J
    Navarro, JR
    BLOOD, 2003, 102 (11) : 461B - 462B
12345